Carles Domènech Garcia
Amministratore Delegato presso Ability Pharmaceuticals SL
Provenienza dei contatti di primo grado di Carles Domènech Garcia
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Ability Pharmaceuticals SL
 Ability Pharmaceuticals SL BiotechnologyHealth Technology Ability Pharmaceuticals SL operates as a clinical stage drug discovery and development biopharmaceutical firm. It develops human therapeutics to treat cancer and other indications with unmet medical needs. The company was founded by Carles Domènech Garcia Jordi Espadaler Mazo in November 2009 and is headquartered in Barcelona, Spain.
9
| Holding Company | Biotechnology | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Carles Domènech Garcia tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AB-BIOTICS, S.A. | Pharmaceuticals: Other | Founder Founder Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
Sevibe Cells SL
 Sevibe Cells SL Medical/Nursing ServicesHealth Services Sevibe Cells SL provides medical and laboratory services. It provides stem cell preservation. The company was founded by Miquel Àngel Bonachera Sierra and Eloi Palà Ramos on August 6, 2007 and is headquartered in Cerdanyola del Valles, Spain. | Medical/Nursing Services | Director/Board Member Founder Chairman Director/Board Member | |
| Escuela Superior de Administración y Dirección de Empresas | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Universitat Autònoma de Barcelona | College/University | Undergraduate Degree Undergraduate Degree | |
| HANNUN S.A. | Home Furnishings | Director/Board Member Director/Board Member | |
| Indiana University | College/University | Graduate Degree | |
Agrasys SL
 Agrasys SL BiotechnologyHealth Technology Agrasys SL develops and commercialize crops and cereals. It offers Tritordeum, a non genetic modification cereals and developed for human nutrition. The company was founded in 2005 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
| EDESA BIOTECH, INC. | Pharmaceuticals: Major | Director/Board Member | |
| London Business School | College/University | Masters Business Admin | |
Biotechnology Development for Industry in Pharmaceuticals SLU
 Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Barcelona | College/University | Undergraduate Degree | |
Zera Intein Protein Solutions SL
 Zera Intein Protein Solutions SL BiotechnologyHealth Technology Zera Intein Protein Solutions SL develops and commercializes biomedical technologies, with applications in the biotechnological, pharmaceutical, veterinary and industrial sectors. Its proprietary technologies include Zera and Splittera. Zera technology is composed of self-assembler peptides for DNA vaccines, carrier-free enzyme immobilization, and biopharmaceutical protein production. Splittera refers to Split Intein technology which includes trans-splicing, cyclization, and cleavage reactions. The company was founded on January 30, 2015 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
AptaTargets SL
 AptaTargets SL Pharmaceuticals: MajorHealth Technology AptaTargets SL is a biopharmaceutical company based in Madrid, Spain that focuses on developing therapeutic applications based on aptamer technology. The Spanish company is currently developing aptoll, an immune modulator that blocks the activation of tlr4 in a stroke, representing a novel approach to treat ischemic stroke in the acute phase. It could also be administered in patients up to 48 hours after the stroke. AptaTargets targets indications where inflammation causes significant damage through clinical studies and successful preclinical development. The company was founded in 2014 by David Segarra and María Eugenia Zarabozo, with David Segarra serving as the CEO since then. | Pharmaceuticals: Major | Director/Board Member | |
Oxolife SL
 Oxolife SL BiotechnologyHealth Technology Oxolife SL operates as an biotech company focused on treating female infertility. The company was founded by Agn?s Arbat and Ignasi Canals in 2013 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
AmacaThera, Inc.
 AmacaThera, Inc. Medical SpecialtiesHealth Technology AmacaThera, Inc. is biotechnology company, which engages in the development and commercialization of injectable hydrogel platform technology. Its platform addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. The company was founded by Molly S. Soichet and Mike Cooke and is headquartered in Toronto, Canada. | Medical Specialties | Director/Board Member | |
| CHEVRON CORPORATION | Integrated Oil | Private Equity Investor | |
Innoup Farma SL
 Innoup Farma SL BiotechnologyHealth Technology InnoUp Farma SL develops nanotechnology-based solutions for the administration of oral drugs. It offers anti-cancer drugs with low oral bioavailability. The company was founded by Maite Agueros Bazo, Manuel Rodriguez Mariscal and Juan Manuel Irache Garreta and is headquartered in Noain, Spain. | Biotechnology | Director/Board Member | |
Avizorex Pharma SL
 Avizorex Pharma SL Medical/Nursing ServicesHealth Services Avizorex Pharma SL develops drugs for the treatment of the dry eye disease. The company was founded by Carlos Belmonte and Sauri Patrick Tresserras in July, 2013 and is headquartered in Barcelona, Spain. | Medical/Nursing Services | Director/Board Member | |
Antalgenics SL
 Antalgenics SL BiotechnologyHealth Technology Antalgenics SL is a Spanish biotechnological company that specializes in discovering and developing new bioactive molecules for biomedical and dermocosmetic applications. The company is based in Alicante, Spain. The company offers customized R & D services to design and develop projects according to the client's needs. The company's focus is on developing novel therapeutic leads, primarily for the treatment of psoriatic pruritus and psoriatic comorbidities. Antalgenics was founded in 2015, and the CEO is Philipp Tsolakis. | Biotechnology | Director/Board Member | |
Connecta Therapeutics SL
 Connecta Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Connecta Therapeutics SL is an innovation-oriented, R&D-intensive organization committed to developing innovative treatments for patients. Connecta Therapeutics is based in Barcelona, ES. The Spanish company strongly believes in improving the lives of patients and their families and understands the importance of teamwork and collaboration to achieve their goals. The company was founded in 2019 by Josep Prous, David Prous, and Jordi Fàbrega. Jordi Fàbrega has been the CEO since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
Inveready Asset Management SGEIC SA
 Inveready Asset Management SGEIC SA Investment ManagersFinance Inveready Asset Management SGEIC SA (Inveready) is a private equity and venture capital subsidiary of Inveready Capital Co. SL founded in 2008 by Joseph Maria Echarri Torres. The firm is headquartered in San Sebastian, Spain. | Investment Managers | Private Equity Investor | |
Alliant Abogados Asociados SLP
 Alliant Abogados Asociados SLP Miscellaneous Commercial ServicesCommercial Services Alliant Abogados Asociados SLP provides legal advisory services. The private company is based in Barcelona, Spain. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Real Club Náutico de Barcelona | Director/Board Member | ||
| Laboratorios Neusc SA | Director/Board Member | ||
| Sandur 2004 SL | President | ||
| Biolittletec SL | President | ||
| Farmagelos SL | President | ||
| Food Genomics SL | Founder | ||
Novartis Medical Nutrition AG
 Novartis Medical Nutrition AG Pharmaceuticals: MajorHealth Technology Novartis Medical Nutrition AG produces clinical nutritional supplements. It specializes in diabetes, oncology, digestive health, obesity, surgical, wound and critical care, malnutrition, dysphagia, and pediatric nutrition. The company was founded in 1996 and is headquartered in Nyon, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| IFFE FUTURA, S.A. | Real Estate Investment Trusts | Director/Board Member |
Statistiche
Distribuzione geografica
| Spagna | 25 |
| Stati Uniti | 3 |
| Canada | 3 |
| Argentina | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 11 |
| Consumer Services | 6 |
| Commercial Services | 4 |
| Health Services | 3 |
| Finance | 3 |
Posizioni
| Director/Board Member | 32 |
| Founder | 5 |
| Undergraduate Degree | 4 |
| Masters Business Admin | 4 |
| Chairman | 4 |
Contatti più connessi
- Borsa valori
- Insiders
- Carles Domènech Garcia
- Connessioni Società
